BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

688 related articles for article (PubMed ID: 11979456)

  • 1. CNS late-effects after ALL therapy in childhood. Part III: neuropsychological performance in long-term survivors of childhood ALL: impairments of concentration, attention, and memory.
    Langer T; Martus P; Ottensmeier H; Hertzberg H; Beck JD; Meier W
    Med Pediatr Oncol; 2002 May; 38(5):320-8. PubMed ID: 11979456
    [TBL] [Abstract][Full Text] [Related]  

  • 2. P300 abnormalities in long-time survivors of acute lymphoblastic leukemia in childhood--side effects of CNS prophylaxis?
    Uberall MA; Haupt K; Meier W; Hertzberg H; Beck JD; Wenzel D
    Neuropediatrics; 1996 Jun; 27(3):130-5. PubMed ID: 8837072
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of long-term neurocognitive outcomes in young children with acute lymphoblastic leukemia treated with cranial radiation or high-dose or very high-dose intravenous methotrexate.
    Spiegler BJ; Kennedy K; Maze R; Greenberg ML; Weitzman S; Hitzler JK; Nathan PC
    J Clin Oncol; 2006 Aug; 24(24):3858-64. PubMed ID: 16921038
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevention of CNS recurrence in childhood ALL: results with reduced radiotherapy combined with CNS-directed chemotherapy in four consecutive ALL-BFM trials.
    Schrappe M; Reiter A; Henze G; Niemeyer C; Bode U; Kühl J; Gadner H; Havers W; Plüss H; Kornhuber B; Zintl F; Ritter J; Urban C; Niethammer D; Riehm H
    Klin Padiatr; 1998; 210(4):192-9. PubMed ID: 9743952
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Late sequelae of CNS recurrence of acute lymphoblastic leukemia in childhood].
    Steinberg S; Hartmann R; Wisniewski S; Berger K; Beck JD; Henze G
    Klin Padiatr; 1998; 210(4):200-6. PubMed ID: 9743953
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Leukoencephalopathy and long-term neurobehavioural, neurocognitive, and brain imaging outcomes in survivors of childhood acute lymphoblastic leukaemia treated with chemotherapy: a longitudinal analysis.
    Cheung YT; Sabin ND; Reddick WE; Bhojwani D; Liu W; Brinkman TM; Glass JO; Hwang SN; Srivastava D; Pui CH; Robison LL; Hudson MM; Krull KR
    Lancet Haematol; 2016 Oct; 3(10):e456-e466. PubMed ID: 27658980
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Late sequelae of central nervous system prophylaxis in children with acute lymphoblastic leukemia: high doses of intravenous methotrexate versus radiotherapy of the central nervous system--review of literature].
    Zając-Spychała O; Wachowiak J
    Med Wieku Rozwoj; 2012; 16(2):128-37. PubMed ID: 22971657
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparative study of the long term psychosocial functioning of childhood acute lymphoblastic leukemia survivors treated by intrathecal methotrexate with or without cranial radiation.
    Hill JM; Kornblith AB; Jones D; Freeman A; Holland JF; Glicksman AS; Boyett JM; Lenherr B; Brecher ML; Dubowy R; Kung F; Maurer H; Holland JC
    Cancer; 1998 Jan; 82(1):208-18. PubMed ID: 9428499
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term cognitive outcome, brain computed tomography scan, and magnetic resonance imaging in children cured for acute lymphoblastic leukemia.
    Iuvone L; Mariotti P; Colosimo C; Guzzetta F; Ruggiero A; Riccardi R
    Cancer; 2002 Dec; 95(12):2562-70. PubMed ID: 12467071
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Almost normal cognitive function in patients during therapy for childhood acute lymphoblastic leukemia without cranial irradiation according to ALL-BFM 95 and COALL 06-97 protocols: results of an Austrian-German multicenter longitudinal study and implications for follow-up.
    Krappmann P; Paulides M; Stöhr W; Ittner E; Plattig B; Nickel P; Lackner H; Schrappe M; Janka G; Beck JD; Langer T
    Pediatr Hematol Oncol; 2007 Mar; 24(2):101-9. PubMed ID: 17454775
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A prospective neurocognitive evaluation of children treated with additional chemotherapy and craniospinal irradiation following isolated central nervous system relapse in acute lymphoblastic leukemia.
    Kumar P; Mulhern RK; Regine WF; Rivera GK; Kun LE
    Int J Radiat Oncol Biol Phys; 1995 Feb; 31(3):561-6. PubMed ID: 7852120
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cerebral glucose metabolism in survivors of childhood acute lymphoblastic leukemia.
    Kähkönen M; Metsähonkala L; Minn H; Utriainen T; Korhonen T; Norvasuo-Heilä MK; Harila-Saari A; Aärimaa T; Suhonen-Polvi H; Ruotsalainen U; Solin O; Salmi TT
    Cancer; 2000 Feb; 88(3):693-700. PubMed ID: 10649265
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Verbal cognitive functioning and learning in girls treated for acute lymphoblastic leukemia by chemotherapy with or without cranial irradiation.
    Précourt S; Robaey P; Lamothe I; Lassonde M; Sauerwein HC; Moghrabi A
    Dev Neuropsychol; 2002; 21(2):173-95. PubMed ID: 12139198
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Progressive neurocognitive impairment in young adult survivors of childhood acute lymphoblastic leukemia.
    Harila MJ; Winqvist S; Lanning M; Bloigu R; Harila-Saari AH
    Pediatr Blood Cancer; 2009 Aug; 53(2):156-61. PubMed ID: 19405135
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cognitive sequelae of treatment in childhood acute lymphoblastic leukemia: cranial radiation requires an accomplice.
    Waber DP; Tarbell NJ; Fairclough D; Atmore K; Castro R; Isquith P; Lussier F; Romero I; Carpenter PJ; Schiller M
    J Clin Oncol; 1995 Oct; 13(10):2490-6. PubMed ID: 7595698
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Response of children with high-risk acute lymphoblastic leukemia treated with and without cranial irradiation: a report from the Children's Cancer Group.
    Nachman J; Sather HN; Cherlow JM; Sensel MG; Gaynon PS; Lukens JN; Wolff L; Trigg ME
    J Clin Oncol; 1998 Mar; 16(3):920-30. PubMed ID: 9508174
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Accretion of bone mass in patients treated for childhood acute lymphoblastic leukemia].
    Muszyńska-Rosłan K; Konstantynowicz J; Krawczuk-Rybak M
    Pol Merkur Lekarski; 2007 Oct; 23(136):271-5. PubMed ID: 18293849
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Central nervous system recurrence in adult patients with acute lymphoblastic leukemia: frequency and prognosis in 467 patients without cranial irradiation for prophylaxis.
    Sancho JM; Ribera JM; Oriol A; Hernandez-Rivas JM; Rivas C; Bethencourt C; Parody R; Deben G; Bello JL; Feliu E;
    Cancer; 2006 Jun; 106(12):2540-6. PubMed ID: 16700036
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cognitive functioning in long-term survivors of childhood leukemia: a prospective analysis.
    Rubenstein CL; Varni JW; Katz ER
    J Dev Behav Pediatr; 1990 Dec; 11(6):301-5. PubMed ID: 2289962
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcomes of a randomized trial of hyperfractionated cranial radiation therapy for treatment of high-risk acute lymphoblastic leukemia: therapeutic efficacy and neurotoxicity.
    Waber DP; Silverman LB; Catania L; Mautz W; Rue M; Gelber RD; Levy DE; Goldwasser MA; Adams H; Dufresne A; Metzger V; Romero I; Tarbell NJ; Dalton VK; Sallan SE
    J Clin Oncol; 2004 Jul; 22(13):2701-7. PubMed ID: 15226337
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 35.